(NP (NP-COOD (NP (NN Corticosteroid) (NNS receptors)) (CC and) (NP (NN lymphocyte) (NNS subsets))) (PP (IN in) (NP (NP (JJ mononuclear) (NNS leukocytes)) (PP (IN in) (NP (NN aging))))) (. .))
(S (NP-SBJ-42 (NP-COOD (NP (NN Plasma) (NN cortisol)) (CC and) (NP (NP (NN aldosterone) (NP-COOD (NP (NNS levels)) (CC and) (NP (NN number)))) (PP (IN of) (NP (JJ related) (NNS receptors))))) (PP (IN in) (NP (JJ mononuclear) (NNS leukocytes)))) (VP (VBD were) (VP (VBN measured) (NP (-NONE- *-42)) (PP-COOD (PP (IN in) (NP (NP (CD 49) (JJ healthy) (JJ aged) (NNS subjects)) (PRN (-LRB- -LRB-) (FRAG (NP (QP (CD 62-97)) (NN yr))) (-RRB- -RRB-)))) (CC and) (PP (IN in) (NP (NP (CD 21) (JJ adult) (NNS controls)) (PRN (-LRB- -LRB-) (FRAG (NP (QP (CD 21-50)) (NN yr))) (-RRB- -RRB-))))))) (. .))
(S (PP (IN In) (NP (DT all) (NNS subjects))) (, ,) (PP (IN in) (NP (NN addition))) (, ,) (NP-SBJ-43 (NN lymphocyte) (NNS subsets)) (VP (VBD were) (VP (VBN determined) (NP (-NONE- *-43)) (PP (IN as) (NP (NP (DT an) (NN index)) (PP (IN of) (NP (NN corticosteroid) (NN action))))))) (. .))
(S (NP-SBJ (NP (DT The) (NN mean) (NN number)) (PP (IN of) (NP (NP-COOD (NP (NN type) (CD I)) (CC and) (NP (NN type) (CD II))) (NNS receptors)))) (VP (VP (VBD was) (ADJP-PRD (ADJP (RB significantly) (JJR lower)) (PP (-NONE- *ICH*-44))) (PP (IN in) (NP (JJ aged) (NNS subjects))) (PP-44 (IN than) (FRAG (PP (IN in) (NP (NNS controls)))))) (PRN (-LRB- -LRB-) (FRAG (ADVP (RB respectively)) (, ,) (NP (NP-COOD (NP (NP (QP (CD 198) (CC (- +)) (CD 96) (CC and) (CD 272) (CC (- +)) (CD 97)) (NNS (cell receptors))) (PP (IN for) (NP (NN type) (CD I) (NP (-NONE- *RNR*-45))))) (, ,) (CC and) (NP (NP (QP (CD 1,794) (CC (- +)) (CD 803) (CC and) (CD 3,339) (CC (- +)) (CD 918))) (PP (IN for) (NP (NN type) (CD II) (NP (-NONE- *RNR*-45)))))) (NP-45 (NNS receptors)))) (-RRB- -RRB-))) (. .))
(S (NP-SBJ-COOD (NP (NN Plasma) (NP-COOD (NP (NN aldosterone)) (CC and) (NP (NN cortisol)))) (CC and) (NP (NN lymphocyte) (NNS subsets))) (VP (VBD were) (RB not) (ADJP-PRD (JJ different)) (PP (IN in) (NP (DT the) (CD two) (NNS groups)))) (. .))
(S-COOD (S (NP-SBJ-46 (NP (DT All)) (PP (IN of) (NP (DT the) (NNS parameters)))) (VP (VBD were) (ADVP (RB also)) (VP (VBN tested) (NP (-NONE- *-46)) (PP (IN for) (NP (NN correlation)))))) (, ,) (CC and) (S (NP-SBJ-47 (DT a) (JJ significant) (JJ inverse) (NN correlation)) (VP (VBD was) (VP (VBN found) (NP (-NONE- *-47)) (PP (IN between) (NP-COOD (NP (NN age)) (CC and) (NP (NP-COOD (NP (NN type) (CD I)) (CC and) (NP (NN type) (CD II))) (NNS receptors)))) (SBAR-TMP (WHADVP-48 (WRB when)) (S (NP-SBJ-49 (DT all) (NNS subjects)) (VP (VBD were) (VP (VBN plotted) (NP (-NONE- *-49)) (CC and) (PP (IN between) (NP (JJ aged) (CC and) (NN CD4) (CC and) (NN age) (CC and) (NN (CD8 CD4)))) (PP (IN in) (NP (DT the) (JJ aged) (NN group))) (ADVP (-NONE- *T*-48))))))))) (. .))
(S (NP-SBJ (DT These) (NNS data)) (VP (VBP show) (SBAR-COOD (SBAR (IN that) (S (NP-SBJ (JJ aged) (NNS subjects)) (VP (VBP have) (NP (NP (NNS reductions)) (PP (IN of) (NP (NN corticosteroid) (NNS receptors))) (SBAR (WHNP-50 (WDT that)) (S (NP-SBJ-51 (-NONE- *T*-50)) (VP (VBP are) (RB not) (VP (VBN associated) (NP (-NONE- *-51)) (PP (IN with) (NP (NP (NN increase)) (PP (IN of) (NP (JJ related) (NNS steroids))))))))))))) (CC and) (SBAR (IN that) (S (NP-SBJ (DT this) (NN situation)) (ADVP (RB probably)) (VP (VBZ represents) (NP (NP (DT a) (NN concomitant)) (PP (IN of) (NP (DT the) (JJ normal) (NN aging) (NN process))))))))) (. .))
